Summary

North America Cosmetic Surgery Market – Scope of Report
TMR’s report on the North America cosmetic surgery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the North America cosmetic surgery market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the North America cosmetic surgery market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the cosmetic surgery market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the North America cosmetic surgery market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the North America cosmetic surgery market. These serve as valuable tools for existing market players as well as for entities interested in participating in the North America cosmetic surgery market.

The report delves into the competitive landscape of the North America cosmetic surgery market. Key players operating in the North America cosmetic surgery market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the North America cosmetic surgery market profiled in this report.

Key Questions Answered in North America cosmetic surgery Market Report
• What is the sales/revenue generated by cosmetic surgery across all regions during the forecast period?
• What are the opportunities in the North America cosmetic surgery market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue North Americaly in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the North America market?

North America Cosmetic Surgery Market – Research Objectives and Research Approach
The comprehensive report on the North America cosmetic surgery market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the North America cosmetic surgery market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the North America cosmetic surgery market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: North America Cosmetic Surgery Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. North America Cosmetic Surgery Market Analysis and Forecasts, 2017 - 2031
5. Key Insights
5.1. Top Overall Cosmetic and Reconstructive Procedures
5.2. Most Performed Surgical Cosmetic Procedures in the United States in 2022
5.3. Surgical & Non-surgical Highlights in United States by Type
5.4. Technological Advances in Cosmetic Surgery
5.5. Covid Impact Analysis
6. North America Cosmetic Surgery Market Analysis and Forecasts, By Procedure Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Procedure Type, 2017 - 2031
6.3.1. Invasive Procedures
6.3.1.1. Breast augmentation
6.3.1.2. Liposuction
6.3.1.3. Nose reshaping
6.3.1.4. Eyelid Surgery
6.3.1.5. Tummy tuck
6.3.1.6. Others
6.3.2. Non-invasive Procedures
6.3.2.1. Botox injections
6.3.2.2. Soft tissue fillers
6.3.2.3. Chemical peel
6.3.2.4. Laser hair removal
6.3.2.5. Microdermabrasion
6.4. Market Attractiveness By Procedure Type
7. North America Cosmetic Surgery Market Analysis and Forecasts, By Gender
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Gender, 2017 - 2031
7.3.1. Female
7.3.2. Male
7.4. Market Attractiveness By Gender
8. North America Cosmetic Surgery Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2017 - 2031
8.3.1. Ambulatory Surgical Facilities
8.3.2. Hospitals and Clinics
8.3.3. Physician Offices and Cosmetic Centers
8.4. Market Attractiveness By End-user
9. North America Cosmetic Surgery Market Analysis and Forecasts, By Country
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. United States
9.2.2. Canada
9.3. Market Attractiveness By Country/Region
10. United States Cosmetic Surgery Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Procedure Type, 2017 - 2031
10.2.1. Invasive Procedures
10.2.1.1. Breast augmentation
10.2.1.2. Liposuction
10.2.1.3. Nose reshaping
10.2.1.4. Eyelid Surgery
10.2.1.5. Tummy tuck
10.2.1.6. Others
10.2.2. Non-invasive Procedures
10.2.2.1. Botox injections
10.2.2.2. Soft tissue fillers
10.2.2.3. Chemical peel
10.2.2.4. Laser hair removal
10.2.2.5. Microdermabrasion
10.3. Market Value Forecast By Gender, 2017 - 2031
10.3.1. Female
10.3.2. Male
10.4. Market Value Forecast By End-user, 2017 - 2031
10.4.1. Ambulatory Surgical Facilities
10.4.2. Hospitals and Clinics
10.4.3. Physician Offices and Cosmetic Centers
10.5. Market Attractiveness Analysis
10.5.1. By Procedure Type
10.5.2. By Gender
10.5.3. By End-user
11. Canada Cosmetic Surgery Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Procedure Type, 2017 - 2031
11.2.1. Invasive Procedures
11.2.1.1. Breast augmentation
11.2.1.2. Liposuction
11.2.1.3. Nose reshaping
11.2.1.4. Eyelid Surgery
11.2.1.5. Tummy tuck
11.2.1.6. Others
11.2.2. Non-invasive Procedures
11.2.2.1. Botox injections
11.2.2.2. Soft tissue fillers
11.2.2.3. Chemical peel
11.2.2.4. Laser hair removal
11.2.2.5. Microdermabrasion
11.3. Market Value Forecast By Gender, 2017 - 2031
11.3.1. Female
11.3.2. Male
11.4. Market Value Forecast By End-user, 2017 - 2031
11.4.1. Ambulatory Surgical Facilities
11.4.2. Hospitals and Clinics
11.4.3. Physician Offices and Cosmetic Centers
11.5. Market Attractiveness Analysis
11.5.1. By Procedure Type
11.5.2. By Gender
11.5.3. By End-user
12. Competition Landscape
12.1. Market Player – Competition Matrix (By Tier and Size of companies)
12.2. Market Share Analysis By Company (2022)
12.3. Company Profiles
12.3.1. Johnson & Johnson
12.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.1.2. Material Portfolio
12.3.1.3. Financial Overview
12.3.1.4. SWOT Analysis
12.3.1.5. Strategic Overview
12.3.2. Bausch Health Companies Inc.
12.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.2.2. Material Portfolio
12.3.2.3. Financial Overview
12.3.2.4. SWOT Analysis
12.3.2.5. Strategic Overview
12.3.3. Cutera, Inc.
12.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.3.2. Material Portfolio
12.3.3.3. Financial Overview
12.3.3.4. SWOT Analysis
12.3.3.5. Strategic Overview
12.3.4. Merz North America, Inc.
12.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.4.2. Material Portfolio
12.3.4.3. Financial Overview
12.3.4.4. SWOT Analysis
12.3.4.5. Strategic Overview
12.3.5. Galderma Laboratories, L.P
12.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.5.2. Material Portfolio
12.3.5.3. Financial Overview
12.3.5.4. SWOT Analysis
12.3.5.5. Strategic Overview
12.3.6. Sientra, Inc.
12.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.6.2. Material Portfolio
12.3.6.3. Financial Overview
12.3.6.4. SWOT Analysis
12.3.6.5. Strategic Overview
12.3.7. Apyx Medical
12.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.7.2. Material Portfolio
12.3.7.3. Financial Overview
12.3.7.4. SWOT Analysis
12.3.7.5. Strategic Overview
12.3.8. Long Island Plastic Surgical Group
12.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.8.2. Material Portfolio
12.3.8.3. Financial Overview
12.3.8.4. SWOT Analysis
12.3.8.5. Strategic Overview
12.3.9. AbbVie Inc.
12.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.9.2. Material Portfolio
12.3.9.3. Financial Overview
12.3.9.4. SWOT Analysis
12.3.9.5. Strategic Overview